INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.
The company's breast cancer screen test has also demonstrated superior accuracy over current tests.
Copyright 2024 – Finance News Network
20 Mar 2023 - Magontec Limited (ASX:MGL) Executive Chairman and CEO Nicholas Andrews discusses the magnesium industry, drivers of demand, China, supply chains into the US and Europe, and recent financial results.
08 Dec 2023 - Stealth Global Holdings reports record FY23 results, driven by efficient consolidation, organic growth, and prudent financial management. CEO Mike Arnold reveals plans for further expansion, M&A, and a commitment to dividends in FY24.
26 Aug 2021 - Chimeric Therapeutics Limited (ASX:CHM) Chief Operating Officer Jennifer Chow talks about the company's licensing of a novel, third-generation CDH17 CAR T cell therapy from the University of Pennsylvania, its recent FDA IND clearance and plans for ongoing growth.
21 Sep 2023 - Brendan Stats - CEO - TMK Energy Limited (ASX:TMK) is a gas exploration company listed on the Australian Stock Exchange. TMK holds a 67% interest in the Gurvantes XXXV Project located in the South Gobi Basin of Mongolia and also holds a 20% interest in the Talisman Depp Project containing the Napoleon Structure located in the Barrow-Dampier Sub-basin.
31 Aug 2020 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director & CEO Garry Crole talks about the company's group strategy, outlook, and much improved FY20 results, despite the challenging operating environment.
14 Nov 2023 - Explore Chariot Corporation (ASX:CC9) US lithium projects with CEO Shanthar Pathmanathan and geological consultant Dr. Edward Max Baker. Discover the progress at the flagship Black Mountain drill and key milestones ahead.
03 Apr 2024 - BIFOX's journey from integrated mining to specialty fertilizer production and its plans for IPO as CEO Tim Koster shares insights on strategy and market growth.
29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
